Redhill Biopharma reported $193.53M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Adamis Pharmaceuticals ADMP:US USD 8.87M 850.2K
Cara Therapeutics CARA:US USD 28.19M 7.02M
Cronos Group Inc CRON:CN USD 37.97M 1.22M
Intra Cellular Therapies ITCI:US USD 77.41M 6.78M